Barinthus Biotherapeutics plc (BRNS) Misses Q2 EPS by 3c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q2 EPS of ($0.43), $0.03 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• Paramount Weighs Tapping Musk For Equity Investment - Semafor
• McDonald's (MCD) Said August In Us Business Was 'slightly Negative' - Bloomberg
• Financial Select Sector SPDR ETF (XLF) call put ratio 1 call to 1.6 puts with focus on 8K contracts of January 50 puts